Absorption of gold from single oral dose of Gold Bhasma [Swarna Bhasma]in human beings

Characterization of Gold Bhasma and its bioavailability study with four different anupana

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2017/10/010135

Enrollment

Registered

2017-10-18

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Swarna Bhasma [ Gold Bhasma ]: market sample , given in 1] 30 mg plain 2] 30 mg with black pepper powder and ghee [Pilot study] 3] 240 mg with black pepper and ghee [pilot study] 4] 3

Eligibility

Inclusion criteria

Inclusion criteria: 1]Healthy human volunteers 2] No acute /chronic signs and symptoms 3] Not taking or previously taken gold containing drugs for last 5 years

Exclusion criteria

Exclusion criteria: 1] Patients of any type 2] Normal persons who too any gold drugs during last 5 years

Design outcomes

Primary

Measure	Time frame
This is a single dose bioavailability study.Timepoint: NA The blood samples to be taken at 0,1,2,3 4,5 hours after administration of study drug	—

Secondary

Measure	Time frame
This is a single dose bioavailability study.Timepoint: 0,1,2,3,5 hours after dose administration	—

Countries

India

Contacts

Public ContactDr Trupti Patil Bhole

Ayurveda Chair , University of Debrecen, Hungary

asmita.wele@gmail.com

Outcome results